Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
2.
BMJ ; 375: n2461, 2021 10 11.
Article in English | MEDLINE | ID: mdl-34635473
3.
Emerg Infect Dis ; 22(4): 590-7, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26982243

ABSTRACT

We evaluated clinical Shiga toxin-producing Escherichia coli O157 infections in England and Wales during 1983-2012 to describe changes in microbiological and surveillance methods. A strain replacement event was captured; phage type (PT) 2 decreased to account for just 3% of cases by 2012, whereas PT8 and PT21/28 strains concurrently emerged, constituting almost two thirds of cases by 2012. Despite interventions to control and reduce transmission, incidence remained constant. However, sources of infection changed over time; outbreaks caused by contaminated meat and milk declined, suggesting that interventions aimed at reducing meat cross-contamination were effective. Petting farm and school and nursery outbreaks increased, suggesting the emergence of other modes of transmission and potentially contributing to the sustained incidence over time. Studies assessing interventions and consideration of policies and guidance should be undertaken to reduce Shiga toxin-producing E. coli O157 infections in England and Wales in line with the latest epidemiologic findings.


Subject(s)
Disease Outbreaks , Escherichia coli Infections/epidemiology , Escherichia coli O157/metabolism , Shiga Toxin/isolation & purification , Shiga-Toxigenic Escherichia coli/metabolism , Adolescent , Adult , Animals , Child , Child, Preschool , Coliphages/classification , Coliphages/genetics , Coliphages/isolation & purification , Communicable Disease Control , England/epidemiology , Epidemiological Monitoring , Escherichia coli Infections/microbiology , Escherichia coli Infections/pathology , Escherichia coli Infections/transmission , Escherichia coli O157/isolation & purification , Escherichia coli O157/pathogenicity , Escherichia coli O157/physiology , Feces/microbiology , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Meat/microbiology , Middle Aged , Milk/microbiology , Molecular Typing , Shiga Toxin/biosynthesis , Shiga-Toxigenic Escherichia coli/pathogenicity , Shiga-Toxigenic Escherichia coli/physiology , Wales/epidemiology
5.
Influenza Other Respir Viruses ; 7(6): 1013-6, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24034594

ABSTRACT

BACKGROUND: Influenza B is often regarded as the milder form of the disease. The early 2012-2013 season in Wales saw the highest rate of influenza B-associated primary care consultations since 1994-1995 and considerable hospitalisations. OBJECTIVES: This report summarises features of the first 100 confirmed cases during 2012-2013 in Wales. METHODS: Case information was sourced from routine laboratory testing and virological surveillance. RESULTS AND CONCLUSIONS: Influenza B (Yamagata lineage) viruses dominated, mainly affecting younger adults, admission to critical care was unexpectedly common. Low vaccine uptake amongst at-risk patients may have contributed to the burden of influenza in secondary care in Wales.


Subject(s)
Influenza B virus/isolation & purification , Influenza, Human/epidemiology , Influenza, Human/virology , Adult , Aged , Female , Hospitalization/statistics & numerical data , Humans , Influenza, Human/pathology , Male , Middle Aged , Primary Health Care/statistics & numerical data , Vaccination/statistics & numerical data , Wales/epidemiology
6.
Emerg Infect Dis ; 17(6): 990-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21749759

ABSTRACT

The United Kingdom implemented a containment strategy for pandemic (H1N1) 2009 through administering antiviral agents (AVs) to patients and their close contacts. This observational household cohort study describes the effect of AVs on household transmission. We followed 285 confirmed primary cases in 259 households with 761 contacts. At 2 weeks, the confirmed secondary attack rate (SAR) was 8.1% (62/761) and significantly higher in persons <16 years of age than in those >50 years of age (18.9% vs. 1.2%, p<0.001). Early (<48 hours) treatment of primary case-patients reduced SAR (4.5% vs. 10.6%, p = 0.003). The SAR in child contacts was 33.3% (10/30) when the primary contact was a woman and 2.9% (1/34) when the primary contact was a man (p = 0.010). Of 53 confirmed secondary case-patients, 45 had not received AV prophylaxis. The effectiveness of AV prophylaxis in preventing infection was 92%.


Subject(s)
Antiviral Agents/therapeutic use , Influenza A Virus, H1N1 Subtype , Influenza, Human/drug therapy , Influenza, Human/transmission , Pandemics , Post-Exposure Prophylaxis , Adolescent , Adult , Aged , Child , Family Characteristics , Female , Humans , Influenza, Human/epidemiology , Influenza, Human/mortality , Kaplan-Meier Estimate , Male , Middle Aged , Pandemics/prevention & control , United Kingdom/epidemiology , Young Adult
7.
J Infect Dis ; 203(1): 18-24, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-21148492

ABSTRACT

We describe the first confirmed person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus that occurred in a hematology unit in the United Kingdom. Eleven cases of (H1N1) 2009 virus infection were identified, of which, ten were related as shown by sequence analysis of the hemagglutinin and neuraminidase genes. H275Y analysis demonstrated that 8 of 10 case patients had oseltamivir-resistant virus, with 4 of 8 case patients infected by direct transmission of resistant virus. Zanamivir should be considered as first-line therapy for influenza in patients with lymphopenic hematological conditions and uptake of influenza vaccination encouraged to further reduce the number of susceptible individuals.


Subject(s)
Antiviral Agents/pharmacology , Drug Resistance, Viral , Influenza A Virus, H1N1 Subtype/drug effects , Influenza, Human/transmission , Influenza, Human/virology , Oseltamivir/pharmacology , Adult , Aged , Amino Acid Substitution/genetics , Cross Infection/transmission , Cross Infection/virology , Hemagglutinins, Viral/genetics , Hospitals , Humans , Influenza A Virus, H1N1 Subtype/isolation & purification , Lymphopenia/complications , Middle Aged , Mutation, Missense , Neuraminidase/genetics , RNA, Viral/genetics , Sequence Analysis, DNA , United Kingdom , Viral Proteins/genetics
8.
BMC Infect Dis ; 10: 141, 2010 May 28.
Article in English | MEDLINE | ID: mdl-20509927

ABSTRACT

BACKGROUND: The detailed analysis of an outbreak database has been undertaken to examine the role of contact tracing in controlling an outbreak of possible avian influenza in humans. The outbreak, initiating from the purchase of infected domestic poultry, occurred in North Wales during May and June 2007. During this outbreak, extensive contact tracing was carried out. Following contact tracing, cases and contacts believed to be at risk of infection were given treatment/prophylaxis. METHODS: We analyse the database of cases and their contacts identified for the purposes of contact tracing in relation to both the contact tracing burden and effectiveness. We investigate the distribution of numbers of contacts identified, and use network structure to explore the speed with which treatment/prophylaxis was made available and to estimate the risk of transmission in different settings. RESULTS: Fourteen cases of suspected H7N2 influenza A in humans were associated with a confirmed outbreak among poultry in May-June 2007. The contact tracing dataset consisted of 254 individuals (cases and contacts, of both poultry and humans) who were linked through a network of social contacts. Of these, 102 individuals were given treatment or prophylaxis. Considerable differences between individuals' contact patterns were observed. Home and workplace encounters were more likely to result in transmission than encounters in other settings. After an initial delay, while the outbreak proceeded undetected, contact tracing rapidly caught up with the cases and was effective in reducing the time between onset of symptoms and treatment/prophylaxis. CONCLUSIONS: Contact tracing was used to link together the individuals involved in this outbreak in a social network, allowing the identification of the most likely paths of transmission and the risks of different types of interactions to be assessed. The outbreak highlights the substantial time and cost involved in contact tracing, even for an outbreak affecting few individuals. However, when sufficient resources are available, contact tracing enables cases to be identified before they result in further transmission and thus possibly assists in preventing an outbreak of a novel virus.


Subject(s)
Contact Tracing , Disease Outbreaks , Influenza A virus/isolation & purification , Influenza, Human/epidemiology , Animals , Health Services Research , Humans , Wales/epidemiology
9.
Emerg Infect Dis ; 14(6): 978-80, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18507920

ABSTRACT

Retrospective testing of 3,232 serum samples from the general population and 518 serum samples from a high-risk group showed no evidence of human exposure to Neospora caninum in England. Results were obtained by using immunofluorescence antibody testing and ELISA to analyze frequency distribution.


Subject(s)
Antibodies, Protozoan/blood , Coccidiosis/epidemiology , Neospora/immunology , Adult , Aged , Animals , Coccidiosis/immunology , England/epidemiology , Enzyme-Linked Immunosorbent Assay/methods , Female , Fluorescent Antibody Technique , Humans , Male , Middle Aged
10.
Clin Infect Dis ; 46(8): 1189-96, 2008 Apr 15.
Article in English | MEDLINE | ID: mdl-18444854

ABSTRACT

BACKGROUND: Preventing household transmission of Shiga toxin-producing Escherichia coli O157 (STEC O157) infection is important because of the ease of interpersonal transmission and the potential disease severity. METHODS: We conducted a retrospective cohort study of households associated with an outbreak of STEC O157 infection in South Wales, United Kingdom, in autumn 2005. We investigated whether characteristics of the primary case patient or the household were predictors for secondary household transmission of STEC O157 infection. Furthermore, we estimated the proportion of cases that might be prevented by isolation (e.g., hospitalization) of the primary case patient immediately after the microbiological diagnosis and the number of patients with STEC O157 who would need to be isolated to prevent 1 case of hemolytic uremic syndrome. Based on dates of symptom onset, case patients in households were classified as having primary, coprimary, or secondary infection. Secondary cases were considered to be preventable if the secondary case patient's symptoms started >1 incubation period (4 days) after the date of microbiological diagnosis of the primary case. RESULTS: Eighty-nine (91%) of 98 eligible households were enrolled. Among 20 households (22%), 25 secondary cases were ascertained. Thirteen secondary cases (56%) occurred in siblings of the primary case patients; hemolytic uremic syndrome developed in 4 of these siblings. Presence of a sibling (risk ratio, 3.8; 95% confidence interval, 0.99-14.6) and young age (<5 years) of the primary case patient (risk ratio, 2.03; 95% confidence interval, 0.99-41.6) were independent predictors for households in which secondary cases occurred. Of the 15 secondary cases for which complete information was available, 7 (46%) might have been prevented. When restricting isolation to primary case patients who were aged <10 years and who had a sibling, we estimated the number of patients who would need to be isolated to prevent 1 case of hemolytic uremic syndrome to be 47 patients (95% confidence interval, 16-78 patients). CONCLUSIONS: Promptly separating pediatric patients with STEC O157 infection from their young siblings should be considered.


Subject(s)
Escherichia coli Infections/prevention & control , Escherichia coli O157/isolation & purification , Shiga-Toxigenic Escherichia coli/isolation & purification , Siblings , Child , Child, Preschool , Cohort Studies , Communicable Disease Control/methods , Escherichia coli Infections/transmission , Humans , Patient Isolation , Retrospective Studies , Wales
14.
BMC Psychiatry ; 4: 32, 2004 Oct 18.
Article in English | MEDLINE | ID: mdl-15491496

ABSTRACT

BACKGROUND: It has been suggested that infection with Toxoplasma gondii is associated with slow reaction and poor concentration, whilst infection with Coxiella burnetii may lead to persistent symptoms of fatigue. METHODS: 425 farmers completed the Revised Clinical Interview Schedule (CIS-R) by computer between March and July 1999 to assess psychiatric morbidity. Samples of venous blood had been previously collected and seroprevalence of T. gondii and C. burnetii was assessed. RESULTS: 45% of the cohort were seropositive for T. gondii and 31% were positive for C. burnetii. Infection with either agent was not associated with symptoms reflecting clinically relevant levels of concentration difficulties, fatigue, depression, depressive ideas or overall psychiatric morbidity. CONCLUSIONS: We do not provide any evidence that infection with Toxoplasma gondii or Coxiella burnetii is associated with neuropsychiatric morbidity, in particular with symptoms of poor concentration or fatigue. However, this is a relatively healthy cohort with few individuals reporting neuropsychiatric morbidity and therefore the statistical power to test the study hypotheses is limited.


Subject(s)
Mental Disorders/epidemiology , Q Fever/epidemiology , Toxoplasmosis/epidemiology , Adult , Aged , Cohort Studies , Comorbidity , Coxiella burnetii , Depressive Disorder/diagnosis , Depressive Disorder/epidemiology , Depressive Disorder/psychology , Diagnosis, Computer-Assisted , England/epidemiology , Female , Humans , Male , Mental Disorders/diagnosis , Mental Disorders/psychology , Mental Fatigue/diagnosis , Mental Fatigue/epidemiology , Mental Fatigue/psychology , Middle Aged , Occupational Exposure , Prevalence , Psychiatric Status Rating Scales , Q Fever/diagnosis , Q Fever/psychology , Retrospective Studies , Seroepidemiologic Studies , Toxoplasmosis/diagnosis , Toxoplasmosis/psychology
15.
Emerg Infect Dis ; 10(7): 1282-9, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15324550

ABSTRACT

An outbreak of Q fever occurred in South Wales, United Kingdom, from July 15 through September 30, 2002. To investigate the outbreak a cohort and nested case-control study of persons who had worked at a cardboard manufacturing plant was conducted. The cohort included 282 employees and subcontractors, of whom 253 (90%) provided blood samples and 214 (76%) completed questionnaires. Ninety-five cases of acute Q fever were identified. The epidemic curve and other data suggested an outbreak source likely occurred August 5-9, 2002. Employees in the factory's offices were at greatest risk for infection (odds ratio 3.46; 95% confidence interval 1.38-9.06). The offices were undergoing renovation work around the time of likely exposure and contained straw board that had repeatedly been drilled. The outbreak may have been caused by aerosolization of Coxiella burnetii spore-like forms during drilling into contaminated straw board.


Subject(s)
Coxiella burnetii , Disease Outbreaks , Industry , Occupational Exposure , Paper , Q Fever/epidemiology , Case-Control Studies , Coxiella burnetii/isolation & purification , Humans
16.
Emerg Infect Dis ; 10(3): 539-41, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15109433

ABSTRACT

We describe the first documented spillover of bovine tuberculosis from animals into the human population of the United Kingdom since the resurgence of the disease in cattle in the country. This finding suggests that there may be a small risk for transmission to humans, making continued vigilance particularly necessary.


Subject(s)
Mycobacterium bovis/pathogenicity , Tuberculosis, Bovine/transmission , Tuberculosis/transmission , Adolescent , Adult , Animals , Cattle , Female , Humans , Male , Mycobacterium bovis/isolation & purification , Tuberculosis/diagnosis , Tuberculosis/physiopathology , United Kingdom
18.
Emerg Infect Dis ; 9(5): 526-30, 2003 May.
Article in English | MEDLINE | ID: mdl-12737734

ABSTRACT

An outbreak of Vero cytotoxin-producing Escherichia coli O157 (VTEC O157) gastroenteritis in visitors to an open farm in North Wales resulted in 17 primary and 7 secondary cases of illness. E. coli O157 Vero cytotoxin type 2, phage type 2 was isolated from 23 human cases and environmental animal fecal samples. A case-control study of 16 primary case-patients and 36 controls (all children) showed a significant association with attendance on the 2nd day of a festival, eating ice cream or cotton candy (candy floss), and contact with cows or goats. On multivariable analysis, only the association between illness and ice cream (odds ratio [OR]=11.99, 95% confidence interval [CI] 1.04 to 137.76) and cotton candy (OR=51.90, 95% CI 2.77 to 970.67) remained significant. In addition to supervised handwashing, we recommend that foods on open farms only be eaten in dedicated clean areas and that sticky foods be discouraged.


Subject(s)
Disease Outbreaks , Escherichia coli Infections/epidemiology , Escherichia coli O157/isolation & purification , Escherichia coli O157/metabolism , Gastroenteritis/epidemiology , Gastroenteritis/microbiology , Shiga Toxins/biosynthesis , Adult , Agriculture , Case-Control Studies , Child , Child, Preschool , Communicable Disease Control , Escherichia coli Infections/complications , Female , Food Microbiology , Gastroenteritis/complications , Hemolytic-Uremic Syndrome/complications , Humans , Male , Risk Factors , Wales/epidemiology
19.
Vaccine ; 20(31-32): 3635-7, 2002 Nov 01.
Article in English | MEDLINE | ID: mdl-12399189

ABSTRACT

In England and Wales routinely available data measure uptake of the measles mumps and rubella (MMR) vaccine at 2 years. This results in a delay in detecting change in uptake of the vaccine, which is scheduled at 12 months of age. The predictive value of uptake at 15-17 months is limited by the greater variability in uptake between quarters at the younger age. This can be overcome by presenting the data as a four-quarter annual rolling average. Uptake of the MMR vaccine at 2 years of age in Wales is predicted to stabilise at around 84% in the first three quarters of 2002.


Subject(s)
Immunization Programs/methods , Immunization Programs/statistics & numerical data , Measles-Mumps-Rubella Vaccine/administration & dosage , Population Surveillance/methods , Child, Preschool , Humans , Immunization Programs/supply & distribution , Immunization Schedule , Infant , Predictive Value of Tests , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...